Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2010
10/19/2010US7816102 producing a kinase/phosphatase inducible domain by replacing a structurally significant glutamic acid or aspartic acid residue in an EF hand domain with a replacement serine or threonine residue; producing a phosphorylation-dependent protein domain; Alzheimer's and heart disease
10/19/2010US7816101 Apparatus for arbitrary peptide synthesis
10/19/2010US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
10/19/2010CA2400667C Modified nodavirus rna for gene delivery
10/19/2010CA2397527C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/19/2010CA2385287C Signal sequences for preparing leu-hirudin by secretion by e. coli into the culture medium
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2365020C Ganp proteins
10/19/2010CA2356845C Novel depsipeptide compound
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2307842C Hyaluronan synthase gene and uses thereof
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010118337A2 Methods of enhancing yield of active iga protease
10/14/2010WO2010118203A2 Endosialin binding molecules
10/14/2010WO2010117984A1 Novel strategies for improved cancer vaccines
10/14/2010WO2010117059A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010091251A3 Modular triple-helical collagen-like products
10/14/2010WO2010065594A3 Cells for increased protein expression comprising one or more release factors and methods of use
10/14/2010WO2010062975A3 Suppressor of ap-1
10/14/2010US20100263092 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation
10/14/2010US20100263091 Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same
10/14/2010US20100261878 Sequences for fk228 biosynthesis and methods of synthesizing fk228 and fk228 analogs
10/14/2010US20100261660 Novel co-stimulatory molecules
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261640 Soluble and membrane anchored forms of lassa virus subunit proteins
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100261227 Production of Proteins Using Transposon-Based Vectors
10/14/2010US20100261218 Methods for producing secondary metabolites
10/14/2010US20100261217 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/14/2010US20100261194 Neutrokine-alpha antibodies and methods of use thereof
10/14/2010US20100261171 Nucleic acid sequences for biosynthesis of non-mccj25-related lariat peptides
10/14/2010US20100260802 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/14/2010US20100260792 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
10/14/2010US20100260785 SARP-1 Fusion Proteins and Uses Thereof
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260769 Endosialin binding molecules
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260763 Polypeptides, antibody variable domains and antagonists methods for
10/14/2010US20100260751 Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
10/14/2010US20100260739 Mirac Proteins
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2750836A1 Anti-siglec-15 antibody
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239267A1 Tag peptide and use thereof
10/13/2010EP2237803A2 Treatment and prophylaxis of amyloidosis
10/13/2010EP1716232B9 Acid alpha-glucosidase and fragments thereof
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010EP1005526B1 Direct expression of peptides into culture media
10/13/2010EP0942971B1 Method for altering the nutritional content of plant seed
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861166A Agent exhibiting properties to form the cellular immunity against mycobacterium tuberculosis H37 Rv, method for the production thereof (variants), a recombinant strain and an agent for tuberculosis diagnosis
10/13/2010CN101857891A Method for preparing donkey bone protein by enzyme method and donkey bone protein instant soup
10/13/2010CN101857851A Mammalian cell culture processes for protein production
10/13/2010CN101857830A Method for preparing eel polypeptide wine
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/12/2010US7812215 Methods and protein production using ovomucoid promoters
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7812135 GITR-binding antibodies
10/12/2010US7812134 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
10/12/2010US7812133 Anti-OX40L antibodies and methods using same
10/12/2010US7812130 fusion protein comprising an isolated soluble cytokine receptor polypeptide; use in treatment of cell proliferative, inflammatory and immune disorders
10/12/2010US7812126 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection
10/12/2010US7811806 Bacillus culture product; nucleic acid
10/12/2010US7811804 synthetic or recombinant polypeptide having a nitrilase activity; have increased activity and stability at increased pH and temperature
10/12/2010US7811801 producing a protein in a cell with a redox active amino acid at a specified position; using an orthogonal-tRNA (O-tRNA) that functions in the cell and recognizes the selector codon and an orthogonal aminoacyl-tRNA synthetase (O-RS) that aminoacylates the O-tRNA with the redox active amino acid
10/12/2010US7811799 Use of endoglucanase 6 in saccharification of biomass; fermenation to bioethanol; biofuels
10/12/2010US7811793 Using trangenic escherichia to generate bone morphogenic protein for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
10/12/2010US7811792 using a hemostasis analyzer is to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811790 Polymyxin synthetase and gene cluster thereof
10/12/2010US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents
10/12/2010US7811788 novel haplotype of the human taste receptor hT2R50 in the T2R taste receptor family that responds to particular bitter ligands, i.e., 2-acetylpyrazine and ethylpyrazine; used as additives in foods, beverages and medicinals for modifying (blocking) hT2R50-associated bitter taste
10/12/2010US7811787 targets for therapeutic intervention in immunological and inflammatory disorders, autoimmune , pulmonary , proliferative immune disorders, and cancer; involved in the negative regulation of intracellular T-cell signal transduction
10/12/2010US7811786 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor
10/12/2010US7811785 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
10/12/2010US7811784 method for manipulation of cells and the resultant cells, wherein at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed; producing a protein by heterologous expression in a host cell
10/12/2010US7811772 Using high density lipoprotein expression pattern as evaluative tool in diagnosis of urogenital cell proliferative disorders
10/12/2010US7811770 Method of detecting a subfraction of proBNP
10/12/2010US7811598 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells
10/12/2010US7811591 comprising non-typeable H. influenzae (NTHi) twitching pilus major subunit protein; otitis media, pneumonia, sinusitis, septicemia, endocarditis, epiglottitis, septic arthritis, meningitis, sepsis, salpingitis, epiglottis, pericardis, cellulitis, osteomyelitis, endocarditis, cholecystitis
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811585 Streptococcus pyogenes antigens
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010CA2497287C Method of humanizing immune system molecules
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1125